|
Volume 271, Number 37,
Issue of September 13, 1996
pp. 22773-22781
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Evidence That the Initial Up-regulation of Phosphatidylcholine
Biosynthesis in Free Cholesterol-loaded Macrophages Is an Adaptive
Response That Prevents Cholesterol-induced Cellular Necrosis
PROPOSED ROLE OF AN EVENTUAL FAILURE OF THIS RESPONSE IN FOAM
CELL NECROSIS IN ADVANCED ATHEROSCLEROSIS*
(Received for publication, May 22, 1996)
Ira
Tabas
,
Sudhir
Marathe
,
George A.
Keesler
,
Nanda
Beatini
and
Yoshimune
Shiratori
From the Departments of Medicine and Anatomy & Cell Biology,
Columbia University College of Physicians and Surgeons, New York,
New York 10032
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
Macrophages in atherosclerotic lesions accumulate
free cholesterol (FC) as well as cholesteryl ester and appear to have
high rates of phospholipid (PL) synthesis and increased PL mass.
Previous short term (i.e. 24 h) studies with cultured
macrophages have shown that these cells respond to FC loading by
up-regulating phosphatidylcholine biosynthesis. We propose that this
response is adaptive by keeping the FC:PL ratio in the macrophages from
reaching toxic levels. We further propose that one cause of macrophage
necrosis, a prominent and important event in atherosclerosis, is an
eventual decrease of this adaptive response. To explore these ideas,
cultured macrophages were loaded with FC for up to 4 days and assayed
for phosphatidylcholine biosynthesis, FC and PL mass, and cytotoxicity.
For the first 24 h, cellular phosphatidylcholine biosynthesis and
FC and PL mass increased 3-4-fold, and thus the FC:PL molar ratio was
prevented from reaching very high levels; at this point, there were no
overt signs of cytotoxicity. Over the next 24-48 h, however,
phosphatidylcholine biosynthesis, and then phosphatidylcholine mass,
began to decrease. Initially, the macrophages remained healthy and
continued to accumulate FC, but eventually these macrophages, but not
unloaded macrophages, became necrotic (swollen organelles and disrupted
membranes). Lipoprotein dose studies indicated a close relationship
between the onset of macrophage necrosis and the FC:PL ratio. To test
further the causal nature of these relationships, cellular FC and PL
mass were independently manipulated by using high density
lipoprotein3 (HDL3) to decrease cellular FC and
choline depletion to decrease cellular PC. As predicted by our
hypotheses, HDL3 protected FC-loaded macrophages from
necrosis, whereas choline depletion accelerated cytotoxic changes.
These findings support the idea that the initial increase in
phosphatidylcholine biosynthesis in FC-loaded macrophages is an
adaptive response that prevents cholesterol-induced macrophage
necrosis. We propose that an eventual failure of the PL response in
foam cells may represent one cause of macrophage necrosis in advanced
atherosclerotic lesions.
INTRODUCTION
Cholesterol-loaded macrophages are prominent features of
atherosclerotic lesions (1, 2, 3), and there is increasing evidence that
these cells play an important role both in early atherogenesis and in
the clinical progression of advanced lesions (4, 5, 6). Although
cholesteryl ester accumulation in lesional macrophages (foam cells) is
often emphasized, these cells also accumulate large amounts of
FC,1 particularly in advanced
atherosclerosis (7, 8, 9, 10). In this light, we have been interested in
elucidating biological responses of macrophages to FC loading. One such
response is the post-translational activation of the
phosphatidylcholine (PC) biosynthetic enzyme, CTP:phosphocholine
cytidylyltransferase (CT), which leads to an increase in PC
biosynthesis and in cellular PC mass (11, 12). This response is likely
to be physiologically important, since increases in PC biosynthesis and
mass have been noted to occur in lesional macrophages in
vivo (13, 14, 15, 16, 17).
We have hypothesized that this PC response is initially adaptive (11,
12), since it would keep the cellular FC:PL ratio from getting too high
and causing damage to cells (see Ref. 18). For example, membranes
enriched with FC demonstrate inhibition of several membrane-bound
enzymes (19, 20, 21, 22), and cholesterol crystals may accumulate in such cells
(14). A corollary of our hypothesis is that an eventual blunting of
this PC response would lead to cellular necrosis, and this scenario may
be one cause of the necrosis of macrophages that is known to occur in
advanced lesions (5, 6, 23, 24). Macrophage necrosis has been proposed
to play an important role in plaque destabilization and thus clinical
progression of lesions (5, 6).
The goal of the present study was to test these ideas using FC-loaded
cultured macrophages. In our previous studies, the macrophages were
FC-loaded for no longer than 24 h, at which point the PC
biosynthetic response was still increasing, and the cells appeared
healthy (11). In the present study, we have cultured these cells for
longer periods, and we found that the PC biosynthetic response, but not
the accumulation of FC, began to decrease after 24 h of culture.
As predicted by our hypotheses, this event caused an increase in the
cellular FC:PL ratio, and the cells subsequently showed signs of
necrosis. Furthermore, removal of cellular FC prevented cytotoxicity,
whereas premature blunting of the PL response accelerated cytotoxicity.
These findings support the idea that the initial increase in PC
biosynthesis in response to FC loading in macrophages is adaptive and
raise the possibility that an eventual blunting of this response may
lead to foam cell necrosis in advanced atherosclerotic lesions.
EXPERIMENTAL PROCEDURES
Materials
The Falcon tissue culture plasticware used in
these studies was purchased from Fisher. Tissue culture media and
reagents were obtained from Life Technologies, Inc., and fetal bovine
serum (FBS) was purchased from Gemini Bioproducts (Calabasas, CA).
Choline-deficient medium, generously provided by Dr. Martin Houweling
(University of Alberta), was made by adding the following supplements
to 5 liters of DMEM, formula 79-5141: NaHCO3 (18.5 g),
D-glucose (22.5 g), L-leucine (525 mg), sodium
pyruvate (550 mg), L-methionine (150 mg), and
L-arginine (420 mg). Lipoprotein-deficient serum (LPDS) was
prepared from fetal bovine serum by preparative ultracentrifugation
(density, 1.21 g/ml) (25).
[methyl-3H]Choline and
[8-3H]adenine (25 Ci/mmol) were purchased
from DuPont NEN. Compound 58035 (3-[decyldimethylsilyl]-N-[2-(4-methylphenyl)-1-phenylethyl]propanamide)
(26) was generously provided by Dr. John Heider of Sandoz, Inc.
(East Hanover, NJ). Stock solutions (10 mg/ml) were prepared in
dimethyl sulfoxide; the final dimethyl sulfoxide concentration in both
treated and control cells was 0.05%. All organic solvents were
purchased from Fisher. Cholesterol (>99% pure) was from Nu-Chek-Prep,
Inc. (Elysian, MN). All other chemicals and reagents were purchased
from Sigma.
Cells
Monolayer cultures of J774.A1 macrophages (from the
American Type Culture Collection) were grown and maintained in spinner
culture with high glucose Dulbecco's modified Eagle's medium (DMEM)
containing 10% (v/v) FBS, penicillin (100 units/ml), streptomycin (100 µg/ml), and glutamine (292 µg/ml) as described previously (27, 28).
Resident mouse peritoneal macrophages were harvested from female ICR
mice (25-30 g); concanavalin A-elicited macrophages were harvested
from the peritoneum of female ICR mice 3 days after the intraperitoneal
injection of 40 µg of concanavalin A in 1 ml of sterile PBS (29). For
each experiment, the cells were plated in 22-mm dishes at an
approximate density of 106 cells/dish (or 35-mm dishes at
2 × 106 cells/dish) in DMEM, 10% FBS and then
incubated at 37 °C in an atmosphere containing 5% CO2.
After 2 h of incubation, the monolayers were washed with warm PBS
and then incubated with DMEM, 10% LPDS alone or containing acetyl-LDL,
58035, or acetyl-LDL plus 58035, as indicated in the individual figure
legends. These media were replaced with fresh media of the same
composition every 12 h.
Lipoproteins and Nonlipoprotein Cholesterol
LDL (density,
1.020-1.063 g/ml) and HDL3 (density, 1.125-1.21 g/ml)
from fresh human plasma were isolated by preparative
ultracentrifugation (25). Acetyl-LDL was prepared by treating LDL with
acetic anhydride as described by Goldstein and co-workers (30). All
concentrations of lipoproteins are given in terms of their protein
content with bovine serum albumin as a standard. All lipoprotein
preparations were stored under argon at 4 °C and used within 4 weeks. Nonlipoprotein cholesterol was added to media from a 20 mg/ml
stock in ethanol; the final concentration of ethanol (also added to
control wells) was 0.25%. Cholesterol-phosphatidylserine liposomes
were made by mixing 2.8 mg of phosphatidylserine and 1.5 mg of
cholesterol (1:1 molar ratio) in chloroform; the solvent was completely
removed by evaporation under nitrogen followed by lyophilization. Three
ml of PBS were added to the dried lipids, and the suspension was
sonicated under argon for 15 4-min bursts at 4 °C using a tapered
microtip on a Branson 450 sonicator (setting number 3).
[3H]Choline Labeling
Experiments
Incorporation of [3H]choline into
phosphatidylcholine in intact cells was determined as described
previously (11). In brief, macrophages incubated under various
conditions were pulsed for 1 h with 2 µCi of
[3H]choline/ml (80.0 Ci/mmol). Lipid extracts of the
cells were then separated by TLC in a solvent system of
chloroform/methanol/acetic acid/water (50:25:8:4, v/v), and the
radioactivity in phosphatidylcholine was quantified. Although the
incorporation of labeled choline into PC can be affected by pool sizes
of precursors, we have previously shown that cellular FC loading does
not affect these pool sizes (11).
Cellular Lipid and Cytotoxicity Assays
Cellular FC and PL
mass measurements were carried out exactly as described by Shiratori
et al. (11). Cell protein content was measured by the method
of Lowry et al. (31), and cell DNA content was determined
using a minor modification (11) of the method of Labarca and Paigen
(32). Cells were loaded with 1 µCi of [3H]adenine and
then assayed for adenine release as described by Warner et
al. (33). Lactate dehydrogenase activity was assayed in medium and
cells as reported previously (34), except a kit purchased from
Sigma (catalogue number 500) was used to measure
enzyme activity; the assay measures the unreacted pyruvic acid using a
colorimetric assay.
Phase Microscopy
Cells in 22-mm tissue culture dishes were
viewed using a Leitz Diavert inverted phase microscope and photographed
using a Nikon camera attached to the microscope.
Electron Microscopy
Cells were plated on 35-mm tissue
culture dishes and incubated for 2 days as indicated. At the end of
incubations, the cells were prepared for electron microscopy as
described previously by our laboratory (35). Briefly, the macrophages
were washed three times with ice-cold 0.13 M sodium
phosphate buffer, pH 7.4 (Buffer C), and then fixed for 30 min at
4 °C in Buffer A containing 3% glutaraldehyde. After three 5-min
washes in Buffer A, the cells were subjected to two sequential 45-min
incubations with 1% OsO4 in Buffer C. These two
incubations and all subsequent procedures were performed at room
temperature in Buffer C. After the OsO4 incubations, the
samples were treated with tannic acid and
p-phenylenediamine, as described by Guyton and Klemp (36).
The cells were then dehydrated using graded ethanol washes and embedded
in Epox (Ernest F. Fullam, Inc., Latham, NY). The embedded samples were
removed from the plastic dishes and sectioned on an MT 6000 ultramicrotome. The sections were stained with uranyl acetate and lead
citrate and examined with a JEOL 1200 EX electron microscope.
Statistics
Unless otherwise indicated, results are given as
means ± S.D. (n = 3); absent error bars in these
figures signify S.D. values smaller than the graphic symbols.
RESULTS
Effects of Prolonged FC Loading of Macrophages on PC Biosynthesis,
Cellular Lipid Content, and Cell Viability
FC loading of cultured
macrophages over a 24-h period leads to an increase in PC biosynthesis
due to post-translational activation of the PC biosynthetic enzyme,
CTP:phosphocholine cytidylyltransferase (CT) (11, 12). This response
results in an increase in cellular PC mass (11). To explore the effects
on PC biosynthesis of more prolonged FC loading, such as occurs in
atheromata (7, 8, 9, 10), macrophages were incubated with 50 µg of
acetyl-LDL/ml plus the ACAT inhibitor 58035 (26) for up to 80 h
(Fig. 1). The data show that after the initial increase
in PC biosynthesis, there is a decline in the rate of this reaction. We
have hypothesized that the initial increase in PC biosynthesis is an
adaptive response that prevents the cellular FC:PL ratio from reaching
potentially toxic levels (11, 12, 18). Thus, in the context of this
hypothesis, the data in Fig. 1 predicted two outcomes: first, that the
FC:PL ratio would rise to high levels in macrophages loaded with FC for
long periods; and second, that the macrophages would eventually show
signs of cytotoxicity. The data in panel A of Fig.
2 show that cellular PL mass rose steeply during the
first 24 h of FC loading, as described previously (11), but then
increased at a slower rate and eventually declined, which is consistent
with the PC biosynthesis data in Fig. 1. PL subclass analysis indicated
that the major species contributing to this trend was PC (data not
shown). FC mass, however, continued to rise at the same rate until the
3rd day of FC loading (panel B). These changes in cellular
lipids resulted in a 3-fold increase in the FC:PL ratio by day 4 of FC
loading (panel C).
Fig. 1.
PC biosynthesis in control and FC-loaded
macrophages over an extended period. Monolayers of J774
macrophages were incubated for the indicated times in DMEM, 10% LPDS
alone (control macrophages, open circles), or DMEM, 10%
LPDS containing 50 µg of acetyl-LDL/ml plus 5 µg of 58035/ml
(FC-loaded macrophages, closed triangles). The cells were
then incubated for 1 h in the same medium containing 2 µCi of
[3H]choline/ml, and the radioactivity in cellular
[3H]phosphatidylcholine was determined.
[View Larger Version of this Image (14K GIF file)]
Fig. 2.
PL and FC mass in control and FC-loaded
macrophages over an extended period. Monolayers of J774
macrophages were incubated for the indicated times in DMEM, 10% LPDS
alone (open circles) or DMEM, 10% LPDS containing 5 µg of
58035/ml (closed circles), 50 µg of acetyl-LDL/ml
(open triangles), or acetyl-LDL plus 58035 (FC-loaded
macrophages, closed triangles). The cells were then assayed
for cellular PL content (panel A) and cellular FC content
(panel B); from these data, the cellular FC:PL ratio was
calculated (panel C).
[View Larger Version of this Image (17K GIF file)]
The second prediction of our hypothesis, namely that the macrophages
would show signs of cytotoxicity after prolonged FC loading, was
investigated using both morphological and biochemical methods.
Morphologically, we noted that the macrophages became rounded and
vacuolated and began to detach from the plate at day 2 of FC loading.
Phase micrographs of control and 3-day FC-loaded macrophages are shown
in Fig. 3. Note that the macrophages incubated with
58035 alone (panel B) or acetyl-LDL alone (panel
C) showed similar density and morphology as control macrophages
(panel A). In contrast, many of the macrophages that were
FC-loaded by incubation with acetyl-LDL plus 58035 had detached from
the plate, and most of those that remained were fragmented and rounded
(panel D). Electron micrographs of control macrophages and
those loaded with FC for 1 and 3 days are shown in Fig.
4. Two major points are revealed by these data. First,
the 1-day FC-loaded cells (panel B) appear morphologically
healthy compared with unloaded macrophages (panel A),
although the loaded cells did contain intracellular membrane whorls, as
described previously (11). These whorls most likely are major sites for
the increased PL mass in FC-loaded cells. Apparently healthy cells were
also noted at 30 h of FC loading (see also below), indicating no
overt cytotoxicity at the time the PC biosynthesis response first began
to decrease (see Fig. 1). Second, the 3-day FC-loaded cells that did
remain attached to the plate (panel C) showed signs of
necrosis, including swollen cytoplasm and disrupted organelles. Careful
inspection of electron micrographs of many 2- and 3-day FC-loaded
macrophages consistently showed these signs, whereas properties of
apoptosis (e.g. fragmented and condensed chromatin,
condensed organelles, and multiple plasma membrane blebs (37)) were not
seen at these times or at 1 day of FC loading. In addition, a
biochemical marker of apoptosis, cleavage of 116-kDa poly(ADP-ribose)
polymerase to an 80-kDa signature fragment by an interleukin
1 -converting enzyme-like protease (38), was not observed at any
stage during FC loading of macrophages (data not shown). Quantitative
biochemical data supporting the morphological observations of both cell
detachment and cytotoxicity are shown in Fig. 5.
Contents of cellular protein (panel A) and DNA (panel
B) decreased by more than 50% in 3-day FC-loaded macrophages,
consistent with a loss of cells from the monolayer. In addition, there
was 2-3-fold increase in the release of intracellular
[3H]adenine (panel C) and LDH (panel
D) from these cells, consistent with cellular necrosis. As with
the morphological observations, these changes were not seen at 30 h of FC loading, the initial time of decrease of PC biosynthesis (Fig.
1). In summary, the data in Figs. 1, 2, 3, 4, 5 are consistent with the notion
that a decline in the initial induction of PC biosynthesis in FC-loaded
macrophages leads to a toxic FC:PL ratio, which, in turn, results in
cellular necrosis.
Fig. 3.
Phase micrographs of control and FC-loaded
macrophages after 3 days of incubation. Monolayers of J774
macrophages were incubated for 3 days in DMEM, 10% LPDS alone
(panel A) or DMEM, 10% LPDS containing 5 µg of 58035/ml
(panel B), 50 µg of acetyl-LDL/ml (panel C), or
acetyl-LDL plus 58035 (FC-loaded macrophages; panel D). The
cells were then viewed by phase microscopy and photographed. The
original microscopy magnification was × 40. Bar, 10 µm.
[View Larger Version of this Image (184K GIF file)]
Fig. 4.
Electron micrographs of control and FC-loaded
macrophages after 1 and 3 days of incubation. Monolayers of J774
macrophages were incubated in DMEM, 10% LPDS alone for 3 days
(panel A) or in DMEM, 10% LPDS containing 50 µg of
acetyl-LDL/ml plus 5 µg of 58035/ml (FC-loaded macrophages) for 1 day
(panel B) or 3 days (panel C). The cells were
then processed for and viewed by electron microscopy. The original
electron microscopy magnification was × 4000. The
arrow in panel B shows a typical intracellular
membrane whorl. Bar, 1 µm.
[View Larger Version of this Image (69K GIF file)]
Fig. 5.
Cell monolayer protein and DNA content and
percent release of [3H]adenine and LDH in control and
FC-loaded macrophages after 3 days of incubation. Monolayers of
J774 macrophages were incubated for 3 days in DMEM, 10% LPDS alone
(diagonal-hatched bars) or DMEM, 10% LPDS containing 5 µg
of 58035/ml (crossed-hatched bars), 50 µg of acetyl-LDL/ml
(open bars), or acetyl-LDL plus 58035 (FC-loaded
macrophages; closed bars). The cells remaining on the
monolayer were then assayed for protein content (panel A)
and DNA content (panel B). In separate experiments,
similarly treated control and FC-loaded macrophages were assayed for
release of [3H]adenine (panel C) and LDH
activity (panel D). The data for [3H]adenine
and LDH release are expressed as ((amount released) (amount released + amount remaining in cells)) × 100.
[View Larger Version of this Image (31K GIF file)]
To further establish the relationship between the cellular FC:PL ratio
and cytotoxicity in FC-loaded macrophages, we incubated the cells with
three different concentrations of acetyl-LDL, all in the presence of
58035 (Fig. 6). At various time points, we measured
cellular FC and PL contents and looked for signs of necrosis using both
morphological (phase microscopy) and biochemical (cellular protein)
criteria, as described above. At 10 µg of acetyl-LDL/ml plus 58035, the cellular FC:PL ratio remained only slightly elevated for up to 4 days, and overt necrosis did not begin until after the 5th day (Fig. 6,
panel A). At 25 µg of acetyl-LDL/ml plus 58035, the FC:PL
ratio increased to a level greater than that seen with the lower
lipoprotein concentration, and necrotic changes began approximately 2 days earlier, at day 3 (panel B). At the highest
concentration of acetyl-LDL (50 µg/ml) plus 58035, the FC:PL ratio
rose steeply, and necrosis began by day 2 (panel C).
Although the absolute FC:PL ratio at which necrosis was triggered in
J774 macrophages varied somewhat between experiments, we usually found
that elevation above 0.4 for >24 h led to these changes. Thus, there
appears to be a close correlation between the FC:PL ratio in
macrophages and the onset of cellular necrosis.
Fig. 6.
Relationship between FC:PL ratio and necrosis
in FC-loaded macrophages. Monolayers of J774 macrophages were
incubated for the indicated times in DMEM, 10% LPDS containing 5 µg
of 58035/ml plus 10 µg (panel A), 25 µg (panel
B), or 50 µg (panel C) of acetyl-LDL/ml. The cells
were then assayed for cellular PL and FC content, and the cellular
FC:PL ratio was calculated from these values. At each time point, the
cells were also examined for signs of necrosis by phase microscopy and
cellular protein content; the arrow labeled with
Necr indicates the time at which the cells started to become
rounded, fragmented, and detached (see Figs. 3 and 5).
[View Larger Version of this Image (11K GIF file)]
The experiments described up to this point were conducted with J774
macrophages, a dividing cell line. To examine these issues in a
nondividing macrophage, we studied both resident and immunologically
primed mouse peritoneal macrophages. The primed macrophages, which are
defined as being able to respond to subsequent stimulation with
lipopolysaccharide, were prepared by injecting the peritoneal cavities
of mice with concanavalin A (Con A) 3 days before harvesting the
peritoneal macrophages (29). Unforeseen differences in
acetyl-LDL-induced cholesterol loading between these two states of
nondividing macrophages provided us an opportunity to test our ideas.
As shown in panel A of Fig. 7, the Con
A-elicited macrophages (closed squares) accumulated more FC
than the resident cells (open squares) when incubated with
acetyl-LDL plus 58035. The increase in PL mass, however, was similar in
both cell types (panel B), and so the FC:PL ratio increased
substantially more in the Con A-elicited cells (panel C).
Morphological observations (not shown) and cellular protein mass data
(panel D) revealed that the Con A-elicited cells eventually
showed signs of necrosis and loss of adherence, whereas the resident
cells remained healthy and adherent throughout 3 days of observation.
Con A-elicited macrophages that were not loaded with FC maintained a
FC:PL ratio of 0.3 and showed no overt signs of cytotoxicity throughout
the 3-day period. Note that peritoneal macrophages appear to be more
resistant to FC-mediated toxicity than J774 macrophages, since a ratio
of 0.7 in resident cells did not lead to necrotic changes during this
time. Nonetheless, the overall principle of a relationship between the
FC:PL ratio and cytotoxicity is established with these nondividing
macrophages.
Fig. 7.
PL and FC mass and cell monolayer protein
content in FC-loaded resident and concanavalin A-elicited mouse
peritoneal macrophages. Monolayers of resident (open
squares) and concanavalin A-elicited (closed squares)
mouse peritoneal macrophages were incubated for the indicated times in
DMEM, 10% LPDS containing 50 µg of acetyl-LDL/ml plus 5 µg of
58035/ml. The cells were then assayed for cellular FC content
(panel A) and cellular PL content (panel B); from
these data, the cellular FC:PL ratio was calculated (panel
C). The cells remaining on the monolayer were then assayed for
protein content (panel D) as in Fig. 5; the 100% values for
the resident and Con A-elicited cells were 0.29 and 0.13 µg/well,
respectively. As mentioned in the text, Con A-elicited macrophages that
were not loaded with FC remained morphologically healthy throughout the
3-day period and showed much less loss of cells from the
monolayer.
[View Larger Version of this Image (23K GIF file)]
Effect of Separate Manipulations of Cellular FC Content and PL
Response in FC-loaded Macrophages
To further define the causal
relationships between PL metabolism, the FC:PL ratio, and cellular
necrosis in FC-loaded macrophages, we conducted one set of experiments
in which FC mass, but not PL mass, was altered, and another set of
experiments in which the PL response, but not FC mass, was manipulated.
In the first set of experiments, macrophages were loaded with FC for
36 h and then chased in medium in the absence or presence of
HDL3, an inducer of cellular cholesterol efflux (39). At
the time of addition of the HDL3 (36 h), the macrophages
had accumulated both FC and PL as expected (Table I),
and the cells showed no signs of necrosis (compare panel D
of Fig. 8 with the control macrophages in panel
A of Fig. 8). The macrophages chased in the absence of
HDL3 continued to accumulate a little more FC, presumably
due to the uptake of residual surface-bound acetyl-LDL and the
processing of prelysosomal acetyl-LDL, whereas those chased in the
presence of HDL3 lost substantial amounts of FC as expected
(Table I). The PL content of these macrophages, however, was very
similar (Table I). As shown in Fig. 8, the macrophages chased in the
absence of HDL3 showed signs of toxicity (compare
panels E (2 days) and F (3 days) with the control
macrophages in panels B and C), whereas those
chased in the presence of HDL3 remained healthy
(panels G and H of Fig. 8). Thus, as predicted by
our hypothesis, preventing the rise in the FC:PL ratio prevented
cytotoxicity.
Fig. 8.
Phase micrographs of control and FC-loaded
macrophages subsequently incubated in the absence or presence of
HDL3. Panels A-C, monolayers of J774
macrophages were incubated in DMEM, 10% LPDS alone and viewed by phase
microscopy at day 1 (A), day 2 (B), and day 3 (C). Panels D-H, other monolayers of J774
macrophages were incubated for 36 h in DMEM, 10% LPDS containing
50 µg of acetyl-LDL/ml plus 5 µg of 58035/ml. The cells were then
washed with PBS and incubated an additional 60 h with DMEM, 10%
LPDS containing 58035 in the absence or presence of 300 µg of
HDL3/ml (see Fig. 8). The cells were viewed at day 1 before
the differential chase (D), at day 2 (minus HDL3 = E; plus HDL3 = G), and at day 3 (minus HDL3 = F; plus HDL3 = H). The original microscopy magnification was × 40. Bar, 10 µm.
[View Larger Version of this Image (190K GIF file)]
In the second set of experiments, our goal was to manipulate the PL
response of FC-loaded macrophages. To accomplish this goal, we took
advantage of the previous finding that incubating cells in
choline-depleted medium partially inhibits PC biosynthesis (40). To
establish this point in our system, we first analyzed the PL content of
control and choline-depleted macrophages, both under
cholesterol-deficient and FC-loading conditions. For these experiments,
it was necessary to load the cells with a source of cholesterol that
did not contain choline-phospholipids, and we chose nonlipoprotein
cholesterol, which is known to modestly up-regulate PC biosynthesis in
macrophages (11). As shown in Table II, choline
deficiency resulted in a relative decrease in the PL content of both
unloaded and FC-loaded macrophages compared with the respective
choline-replete cells. The phase micrographs of these cells are shown
in Fig. 9. Importantly, choline depletion in the absence
of FC loading did not result in cytotoxicity under the conditions of
our experiment (compare the macrophages in panel B with the
control cells in panel A). When loaded with nonlipoprotein
cholesterol, the choline-replete macrophages remained healthy
(panel C), whereas the choline-depleted cells showed
definite signs of cytotoxicity, including detachment, rounding, and
fragmentation (panel D); cellular protein measurements
confirmed this finding (not shown). Similar data were obtained with
macrophages loaded with cholesterol-phosphatidylserine liposomes as
another source of cholesterol without choline (compare the
choline-depleted cells in panel F with the choline-replete
cells in panel E). Thus, partially blunting the PL response
in FC-loaded macrophages promotes cytotoxicity, as predicted by our
hypothesis.2
Table II.
PL mass in control and FC-loaded macrophages incubated in normal or
choline-free medium
Monolayers of J774 macrophages were preincubated for 18 h in DMEM,
10% LPDS or in choline-free DMEM, 10% LPDS. The cells were then
incubated for 2 days in the same respective media plus 5 µg/ml 58035 alone (Control and Choline-free) or containing 50 µg of
nonlipoprotein cholesterol/ml (FC-loaded and choline-free, FC-loaded).
At the end of the incubation, the cells were assayed for cellular PL
content.
| Conditions of
incubation |
Cellular PL content
|
|
|
nmol/mg cell
protein |
| Control |
129.8 ± 1.6
|
| Choline-free |
104.8 ± 0.4 |
| FC-loaded |
161.0 ± 4.8
|
| Choline-free, FC-loaded |
133.1 ± 4.0 |
|
Fig. 9.
Phase micrographs of control and FC-loaded
macrophages incubated in normal or choline-free medium. Monolayers
of J774 macrophages were preincubated for 18 h in DMEM, 10% LPDS
or in choline-free DMEM, 10% LPDS. The cells were then incubated for 2 days in the same respective media plus 5 µg/ml 58035 alone (normal
media = panel A; choline-free media = panel
B), or containing 50 µg of nonlipoprotein cholesterol/ml (normal
media = panel C; choline-free media = panel
D), or containing 50 µg of cholesterol in phosphatidylserine
liposomes (normal media = panel E; choline-free
media = panel F). The cells were then viewed by phase
microscopy and photographed; the original microscopy magnification
was × 40. Bar, 10 µm.
[View Larger Version of this Image (126K GIF file)]
DISCUSSION
As summarized in Fig. 10, the findings in this
report support the hypothesis that the initial rise in PC biosynthesis
in FC-loaded macrophages is an adaptive response that keeps the FC:PL
ratio from rising to toxic levels. This idea likely explains the lag in
the onset of FC-mediated cytotoxicity observed in our study as well as
that of Warner et al. (33), which did not look at cellular
PL metabolism. With prolonged FC loading, however, this adaptive
response fails, the FC:PL ratio rises to cytotoxic levels, and
macrophage necrosis ensues. Although we did not study the exact cause
of macrophage death in these studies, high cellular FC levels are known
to inhibit several critical membrane enzymes, including
Na+/K+-ATPase activity (19),
Ca2+/Mg2+-ATPase activity (20), carnitine
palmitoyltransferase activity (21), and alkaline phosphatase activity
(22). Furthermore, as Small (14) points out, excessive accumulation of
cholesterol monohydrate crystals could lead to lysosomal rupture and
cellular necrosis. In the case of membrane enzyme inhibition, the cause
of FC-induced toxicity is probably related to perturbations of membrane
fluidity, which could be compensated by increases in membrane
phospholipid content (18). Cholesterol crystal formation would also be
expected to be prevented by increases in cellular PL (14).
Interestingly, mouse peritoneal macrophages appear to require a higher
FC:PL ratio than J774 macrophages to trigger cytotoxic changes (Fig.
7). Investigation into the mechanism of this relative resistance may
shed additional light on how cells adapt to excess FC.
Fig. 10.
Model of PC-adaptive response, eventual
decline of the response, and necrosis in FC-loaded macrophages.
Macrophages encounter and internalize atherogenic lipoproteins in the
subendothelial matrix of developing lesions, thereby accumulating
excess cellular cholesterol. In early lesions, much of this cholesterol
is esterified by the ACAT pathway, leading to the cholesteryl ester
(CE)-filled foam cell. In later lesions, however, there is a
progressive increase in cellular FC content, perhaps due to a
disruption in cholesterol transport to ACAT, a failure of ACAT itself,
or an increase in hydrolysis of cholesteryl ester stores by neutral
cholesteryl ester hydrolase (NCEH). The increase in cellular
FC, particularly lysosomal FC, leads to the post-translational
activation of CT via a signaling pathway involving protein
dephosphorylation. Activation of CT, in turn, results in an increase in
cellular PC mass, the bulk of which appears to be stored in
intracellular membrane whorls. We hypothesize that this response is
adaptive by keeping the FC:PL ratio from reaching cytotoxic levels. We
further propose that this initially adaptive response eventually
diminishes, perhaps due to deactivation of CT (e.g. by
cytokines), leading to an increase in the cellular FC:PL ratio and,
ultimately, cholesterol-induced cellular necrosis. Refer to text and
Refs. 11, 12 for details.
[View Larger Version of this Image (12K GIF file)]
The FC-loaded macrophages used in our studies are noted to
have intracellular membrane whorls (see Ref. 11 and
Fig. 4, panel B), which probably represent the sites where
most of the increased PL mass in these cells accumulate. Furthermore,
filipin-labeling studies have shown that much of the FC that
accumulates in cultured macrophages incubated with acetyl-LDL plus
58035 is localized in perinuclear lysosomes, presumably in lysosomal
membranes (12). These findings suggest that our experimental model may
reflect physiological events, since lesional macrophages in
vivo have both intracellular membrane whorls (10) and accumulate
FC in lysosomes (41, 42). These observations raise questions, however,
about how the increased phospholipid might protect the cells from
FC-mediated toxicity. First of all, where in the cell does the
accumulation of FC cause problems? Many of the enzymes inhibited by
excess FC are localized in the plasma membrane (see above), and Warner
et al. (33) have shown that FC export from the lysosomes is
necessary for FC-mediated toxicity in macrophages. Thus, even though
the bulk of FC appears to be in lysosomes, a critical amount of excess
FC is probably in other cellular membranes, particularly the plasma
membrane, and this localization is likely important for FC-mediated
toxicity. Interestingly, we have shown that PC synthesis is still
stimulated when lysosomal FC export is blocked (12), suggesting that
lysosomal FC, while itself not initially toxic, may be the signal to
``warn'' the cell to protect other membranes from ensuing FC
enrichment and damage. Eventually, massive lysosomal FC accumulation
after very prolonged FC loading may result in cholesterol
crystallization (43); consistent with this idea, cholesterol
crystallization appears to be a relatively late effect of FC loading,
since we have not observed it in our cells even after 3 days of
incubation with acetyl-LDL plus 58035.
How does the presence of intracellular membrane whorls pertain to the
proposed ability of increased cellular PL to protect macrophages from
FC-mediated toxicity? One possibility is that the membrane whorls serve
as a ``sink'' for excess cellular cholesterol; for example, a
critical amount of excess cholesterol from the sites of sensitive
membrane enzymes (e.g. plasma membrane) might be transferred
to the whorls, thus preventing inhibition of these enzymes (see above).
Another idea is that the whorls represent a storage form of
``excess'' phospholipid in FC-loaded macrophages; in this scenario,
phospholipid would be transferred from the whorls to membranes in the
cells that have a high FC:PL (cf. Ref. 44). If such
cholesterol or phospholipid transfer reactions are, in fact, found to
play a role in the adaptive response of macrophages to FC loading, a
defect in these transfer reactions might contribute to or accelerate
FC-mediated cytotoxicity.
Two important issues related to our studies but not addressed herein
are the mechanisms of FC accumulation in vivo and the
mechanism of blunting of the PC biosynthetic response with prolonged FC
loading. Regarding the first issue, cells normally possess several
mechanisms to prevent the accumulation of excess FC. These include
cellular cholesterol efflux, cholesterol esterification,
down-regulation of LDL receptors and of endogenous cholesterol
biosynthesis, and cholesterol metabolism (e.g. bile acid
synthesis in hepatocytes) (39, 45, 46). For macrophages internalizing
large amounts of lipoprotein-cholesterol by means other than the LDL
receptor (e.g. via the scavenger receptor), several of these
mechanisms are irrelevant, including receptor down-regulation,
down-regulation of cholesterol biosynthesis, and metabolism of
cholesterol into bile. In lesions, cholesterol efflux may be impeded
due to inaccessibility of the cells to inducers of efflux, or it may be
overwhelmed by the large amount of cholesterol in the cells. Similarly,
the esterification pathway may be saturated or inhibited; for example,
oxysterols in oxidized LDL may prevent trafficking of
lipoprotein-cholesterol to ACAT (47), or ACAT itself may become
dysfunctional in advanced foam cells.
With respect to PC biosynthesis, the initial up-regulation in response
to FC loading is due to post-translational activation of the enzyme
CTP:phosphocholine cytidylyltransferase (CT) (12); specifically,
FC-mediated induction appears to involve a cell-signaling event
involving the dephosphorylation of CT and probably other cellular
proteins (12). The cause of the eventual blunting of the PC
biosynthesis response in our cell-culture model and whether it is
related to a decline in CT activity (e.g. through changes in
CT phosphorylation state) require further investigation. According to
our working hypothesis, blunting of the PC biosynthesis response is an
early event that subsequently causes a rise in the FC:PL
ratio and FC-induced macrophage necrosis. We base this idea on the
finding that PC biosynthesis started to decline at 24 h of FC
loading (Fig. 1), while the first signs of necrosis were seen 24 h
later. It is possible, however, that the blunting of the PC
biosynthesis response itself is a very early result of
subtle FC-induced toxicity, which then causes an escalation in the rise
of the cellular FC:PL ratio. Assaying the sensitivity of CT and the
other membrane-bound PC biosynthetic enzymes to changes in membrane FC
content in vitro may shed light on this idea. In
vivo, it is also possible that certain cytokines blunt the PC
biosynthesis response to FC loading. For example, there is evidence
that tumor necrosis factor- , which is synthesized and secreted by
macrophages in response to a variety of factors (48, 49) and is known
to be present in atherosclerotic lesions (50, 51), can inhibit cellular
PC biosynthesis in alveolar cells (52).
We feel that the major impact of this work is that it provides at least
one plausible explanation for macrophage necrosis in atherosclerotic
lesions. Necrosis of macrophages in advanced atherosclerosis is thought
to be an important event in lesion progression (5, 6, 23, 24). For
example, degradative enzymes released from these cells might contribute
to plaque rupture and eventual acute thrombosis (5, 6). The mechanism
of cellular necrosis in atheromata, however, is not known. In addition
to our hypothesis, other possibilities include nutrient deprivation,
loss of growth factors, free radical and oxidized lipid injury, and
toxic cytokines (for example, see Ref. 53). Heinle (54) attempted to
test the importance of oxygen deprivation and glycogen depletion in
lesional cell necrosis in the absence or presence of lipids by
comparing two types of rabbit carotid lesions, proliferative lesions
alone and proliferative lesions with fatty deposits. Although both
lesions had a similar degree of glucose and glycogen depletion and of
lactate accumulation, necrosis was only associated with the fatty
lesions. This led the author to conclude that some factor other than or
in addition to hypoxia is necessary for lesion necrosis and that the
factor must be related to lipids in the lesions. This conclusion is
consistent with our hypothesis as well as with hypotheses implicating
other toxic lipids. In this regard, we did consider the possibility
that the generation of lysophosphatidylcholine (lyso-PC), which can be
cytotoxic (55, 56), contributed to the necrosis of FC-loaded, PL-rich
macrophages. In preliminary studies, we found that lyso-PC levels are
only slightly elevated before the onset of necrosis, but they are
markedly elevated in the medium after necrosis. Thus, although we have
no evidence that lyso-PC generation causes necrosis of FC-loaded
macrophages, it may be an important consequence of this event due to
released cellular phospholipase A2 acting on accumulated
PC. This lyso-PC may then accelerate the necrosis of neighboring cells
or contribute to specific atherogenic effects thought to be signaled by
this lipid (cf. Refs. 57, 58, 59).
Our hypotheses predict that manipulations resulting in a decrease in
the PL content of lesional cells might accelerate lesion necrosis and
progression. Investigators several decades ago studied the vessels of
rats on a partially choline-deficient diet, which is known to partially
decrease the phosphatidylcholine (PC) content of cells in culture (40)
and in liver in vivo (60). Interestingly, when these rats
were fed cholesterol and saturated fat, there was evidence of
accelerated atherosclerosis in the aorta and coronary arteries,
including increased lesion necrosis (Ref. 61 and references therein).
Although the etiology of the accelerated atherosclerosis in this
situation is not known and may be multifactorial, it is tempting to
speculate that at least part of the mechanism may be related to our
hypothesis about the cytotoxicity of increased FC:PL ratios. The
current goal of our laboratory is to test our hypotheses in
vivo by genetically manipulating arterial wall PL metabolism using
induced-mutant mouse models. By crossing these mice to currently
available mouse models of atherosclerosis, we hope to be able to show
the important role of macrophage PL metabolism in macrophage necrosis
and lesion progression.
FOOTNOTES
*
This work was supported by a Postdoctoral Training Grant in
Nutrition (to S. M.), a National Research Service Award (to
G. A. K.), and Grants HL-39703, HL-21006, and HL-54591 (to I. T.)
from the National Institutes of Health, and a Participating Laboratory
Award (to Y. S.) and a grant-in-aid (to I. T.) from the American
Heart Association, New York City Affiliate. The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
``advertisement'' in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Medicine,
Columbia University, 630 W. 168th St., New York, NY 10032. Tel.:
212-305-9430; Fax: 212-305-5052; E-mail: iat1{at}columbia.edu.
1
The abbreviations used are: FC, free
cholesterol; ACAT, acyl-CoA:cholesterol O-acyltransferase;
CT, CTP:phosphocholine cytidylyltransferase; Con A, concanavalin A;
DMEM, Dulbecco's modified Eagle's medium; FBS, fetal bovine serum;
HDL3, high density lipoprotein3; LDH, lactate
dehydrogenase; LDL, low density lipoprotein; LPDS,
lipoprotein-deficient serum; PBS, phosphate-buffered saline; PC,
phosphatidylcholine; PL, phospholipid; lyso-PC,
lysophosphatidylcholine.
2
Theoretically, the data in Fig. 9 could be explained
by choline deficiency increasing cellular FC content instead of, or in
addition to, its proven effect in decreasing cellular PL content.
Unfortunately, cellular FC measurements were difficult to interpret,
since a substantial amount of both cholesterol added directly to
medium, in the form of microcrystals (62), as well as
cholesterol-phosphatidylserine liposomes stick to the cell surface.
Thus, the FC:PL ratio could not be compared with the previous
experiments using acetyl-LDL as the source of cholesterol. Nonetheless,
there was no evidence that choline deficiency increased
cellular FC. For example, the FC contents of marcophages not exposed to
exogenous cholesterol were 44.8 ± 0.1 (choline-replete) and 40.9 ± 0.1 (choline-depleted) nmol/mg cell protein; in cells exposed to
cholesterol added directly to medium, the FC contents of control and
choline-depleted cells were 280.5 ± 4.8 and 264.8 ± 8.7 nmol/mg cell
protein, respectively.
Acknowledgments
We thank Dr. Paul Skiba for assistance in the
LDH and DNA assays, Inge Hansen for technical assistance with the
gas-liquid chromatography, Dr. Scott Schissel for helping with the
macrophage FC loading experiments, Dr. Martin Houweling (University of
Alberta, Edmonton, Canada) for providing us with choline-deficient
medium, and Dr. Guy Poirier (University of Laval, Quebec City, Canada)
for supplying the anti-mouse poly(ADP-ribose) polymerase antibody
(C-2-10) used for an immunoblot assay of apoptosis-associated cellular
protease activity.
REFERENCES
-
Schaffner, T.,
Taylor, K.,
Bartucci, E. J.,
Fischer-Dzoga, K.,
Beeson, J. H.,
Glagov, S.,
Wissler, R. W.
(1980)
Am. J. Pathol.
100,
57-73
[Abstract]
-
Gerrity, R. G.
(1981)
Am. J. Pathol.
103,
181-190
[Abstract]
-
Faggioto, A.,
Ross, R.,
Harker, L.
(1984)
Arteriosclerosis
4,
323-340
[Abstract/Free Full Text]
-
Smith, J. D.,
Trogan, E.,
Ginsberg, M.,
Grigaux, C.,
Tian, J.,
Miyata, M.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
8264-8268
[Abstract/Free Full Text]
-
Libby, P.,
Clinton, S. K.
(1993)
Curr. Opin. Lipidol.
4,
355-363
[CrossRef]
-
Fuster, V.,
Badimon, L.,
Badimon, J. J.,
Chesebro, J. H.
(1992)
N. Engl. J. Med.
326,
242-250
[Medline]
[Order article via Infotrieve]
-
Katz, S. S.,
Shipley, G. G.,
Small, D. M.
(1976)
J. Clin. Invest.
58,
200-211
-
Lundberg, B.
(1985)
Atherosclerosis
56,
93-110
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rapp, J. H.,
Connor, W. E.,
Lin, D. S.,
Inahara, T.,
Porter, J. M.
(1983)
J. Lipid Res.
24,
1329-1335
[Abstract]
-
Fowler, S.
(1980)
Acta Med. Scand. Suppl.
642,
151-158
[Medline]
[Order article via Infotrieve]
-
Shiratori, Y.,
Okwu, A. K.,
Tabas, I.
(1994)
J. Biol. Chem.
269,
11337-11348
[Abstract/Free Full Text]
-
Shiratori, Y.,
Houweling, M.,
Zha, X.,
Tabas, I.
(1995)
J. Biol. Chem.
270,
29894-29903
[Abstract/Free Full Text]
-
Buck, R. C.,
Rossiter, R. J.
(1951)
Arch. Pathol.
51,
224-230
-
Small, D. M.
(1988)
Arteriosclerosis
8,
103-129
[Abstract/Free Full Text]
-
Zilversmit, D. B.,
Shore, M. L.,
Ackerman, R. F.
(1954)
Circulation
9,
581-585
[Medline]
[Order article via Infotrieve]
-
Day, A. J.,
Wahlqvist, M. L.
(1969)
Exp. Mol. Pathol.
11,
263-274
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wahlqvist, M. L.,
Day, A. J.
(1969)
Exp. Mol. Pathol.
11,
275-284
[CrossRef][Medline]
[Order article via Infotrieve]
-
Jackson, R. L., and Gotto, A. M., Jr. (1976) Atheroscler. Rev.
1, 1-21
-
Yeagle, P. L.
(1983)
Biochim. Biophys. Acta
727,
39-44
[Medline]
[Order article via Infotrieve]
-
Ortega, A.,
Mas-Oliva, J.
(1986)
Biochem. Biophys. Res. Commun.
139,
868-874
[CrossRef][Medline]
[Order article via Infotrieve]
-
Kashfi, K.,
Dory, L.,
Cook, G. A.
(1991)
Biochem. Biophys. Res. Commun.
177,
1121-1126
[CrossRef][Medline]
[Order article via Infotrieve]
-
Brasitus, T. A.,
Dahiya, R.,
Dudeja, P. K.,
Bissonnette, B. M.
(1988)
J. Biol. Chem.
263,
8592-8597
[Abstract/Free Full Text]
-
Ross, R.
(1993)
Nature
362,
801-809
[CrossRef][Medline]
[Order article via Infotrieve]
-
Guyton, J. R.,
Klemp, K. F.
(1996)
Arterioscler. Thromb. Vasc. Biol.
16,
4-11
[Free Full Text]
-
Havel, R. J.,
Eder, H.,
Bragdon, J.
(1955)
J. Clin. Invest.
34,
1345-1353
-
Ross, A. C.,
Go, K. J.,
Heider, J. G.,
Rothblat, G. H.
(1984)
J. Biol. Chem.
259,
815-819
[Abstract/Free Full Text]
-
Khoo, J. C.,
Miller, E.,
McLoughlin, P.,
Tabas, I.,
Rosoff, W. J.
(1989)
Biochim. Biophys. Acta
1012,
215-217
[Medline]
[Order article via Infotrieve]
-
Okwu, A. K.,
Xu, X.-X.,
Shiratori, Y.,
Tabas, I.
(1994)
J. Lipid Res.
35,
644-655
[Abstract]
-
Smith, C. W.,
Goldman, A. S.
(1972)
Exp. Cell Res.
73,
394-398
[CrossRef][Medline]
[Order article via Infotrieve]
-
Basu, S. K.,
Goldstein, J. L.,
Anderson, R. G. W.,
Brown, M. S.
(1976)
Proc. Natl. Acad. Sci. U. S. A.
73,
3178-3182
[Abstract/Free Full Text]
-
Lowry, O. H.,
Rosebrough, N. J.,
Farr, A. L.,
Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275
[Free Full Text]
-
Labarca, C.,
Paigen, K.
(1980)
Anal. Biochem.
102,
344-352
[CrossRef][Medline]
[Order article via Infotrieve]
-
Warner, G. J.,
Stoudt, G.,
Bamberger, M.,
Johnson, W. J.,
Rothblat, G. H.
(1995)
J. Biol. Chem.
270,
5772-5778
[Abstract/Free Full Text]
-
Korzeniewski, C.,
Callewaert, D. M.
(1983)
J. Immunol. Methods
64,
313-320
[CrossRef][Medline]
[Order article via Infotrieve]
-
Tabas, I.,
Li, Y.,
Brocia, R. W.,
Xu, S. W.,
Swenson, T. L.,
Williams, K. J.
(1993)
J. Biol. Chem.
268,
20419-20432
[Abstract/Free Full Text]
-
Guyton, J. R.,
Klemp, K. F.
(1988)
J. Histochem. Cytochem.
36,
1319-1328
[Abstract]
-
Arends, M. J.,
Wyllie, A. H.
(1991)
Int. Rev. Exp. Pathol.
32,
223-254
[Medline]
[Order article via Infotrieve]
-
Lazebnik, Y. A.,
Kaufmann, S. H.,
Desnoyers, S.,
Poirier, G. G.,
Earnshaw, W. C.
(1994)
Nature
371,
346-347
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rothblat, G. H.,
Mahlberg, F. H.,
Johnson, W. J.,
Phillips, M. C.
(1992)
J. Lipid Res.
33,
1091-1097
[Abstract]
-
Cornell, R.,
MacLennan, D. H.
(1985)
J. Biol. Chem.
260,
1290-1295
[Abstract/Free Full Text]
-
Shio, H.,
Haley, N. J.,
Fowler, S.
(1979)
Lab. Invest.
41,
160-167
[Medline]
[Order article via Infotrieve]
-
Jerome, W. G.,
Lewis, J. C.
(1985)
Am. J. Pathol.
119,
210-222
[Abstract]
-
Tangirala, R. K.,
Jerome, W. G.,
Jones, N. L.,
Small, D. M.,
Johnson, W. J.,
Glick, J. M.,
Mahlberg, F. H.,
Rothblat, G. H.
(1994)
J. Lipid Res.
35,
93-104
[Abstract]
-
Crain, R. C.,
Zilversmit, D. B.
(1980)
Biochemistry
19,
1433-1439
[CrossRef][Medline]
[Order article via Infotrieve]
-
Brown, M. S.,
Goldstein, J. L.
(1986)
Science
232,
32-47
-
Russel, D. W.
(1992)
Cardiovasc. Drugs Ther.
6,
103-110
[CrossRef][Medline]
[Order article via Infotrieve]
-
Maor, I.,
Mandel, H.,
Aviram, M.
(1995)
Arterioscler. Thromb. Vasc. Biol.
15,
1378-1387
[Abstract/Free Full Text]
-
Vassalli, P.
(1992)
Annu. Rev. Immunol.
10,
411-452
[CrossRef][Medline]
[Order article via Infotrieve]
-
Renier, G. E.,
Skamene, J. B.,
DeSanctis, B.,
Radzioch, D.
(1994)
J. Lipid Res.
35,
271-278
[Abstract]
-
Brown, M. S.,
Goldstein, J. L.
(1983)
Annu. Rev. Biochem.
52,
223-261
[CrossRef][Medline]
[Order article via Infotrieve]
-
Schechter, I.,
Fogelman, A. M.,
Haberland, M. E.,
Seager, J.,
Hokom, M.,
Edwards, P. A.
(1981)
J. Lipid Res.
22,
63-71
[Abstract]
-
Arias-Díaz, J.,
Vara, E.,
García, C.,
Balibrea, J.
L.
(1994)
J. Clin. Invest.
94,
244-250
-
Coffey, M. D.,
Cole, R. A.,
Colles, S. M.,
Chisolm, G. M.
(1995)
J. Clin. Invest.
96,
1866-1873
-
Heinle, H.
(1987)
Exp. Mol. Pathol.
46,
312-320
[CrossRef][Medline]
[Order article via Infotrieve]
-
Weltzien, H. U.
(1979)
Biochim. Biophys. Acta
559,
259-287
[Medline]
[Order article via Infotrieve]
-
Niewoehner, D. E.,
Rice, K.,
Duane, P.,
Sinha, A. A.,
Gebhard, R.,
Wangensteen, D.
(1989)
J. Appl. Physiol.
66,
261-267
[Abstract/Free Full Text]
-
Quinn, M. T.,
Parthasarathy, S.,
Steinberg, D.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
2805-2809
[Abstract/Free Full Text]
-
Kume, N.,
Cybulsky, M. I.,
Gimbrone, M. A.
(1992)
J. Clin. Invest.
90,
1138-1144
-
Nakano, T.,
Raines, E. W.,
Abraham, J. A.,
Klagsbrun, M.,
Ross, R.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
1069-1073
[Abstract/Free Full Text]
-
Yao, Z.,
Jamil, H.,
Vance, D. E.
(1990)
J. Biol. Chem.
265,
4326-4331
[Abstract/Free Full Text]
-
Salmon, W. D.,
Newberne, P. M.
(1962)
Arch. Pathol.
73,
190-209
[Medline]
[Order article via Infotrieve]
-
Haberland, M. E.,
Reynolds, J. A.
(1973)
Proc. Natl. Acad. Sci. U. S. A.
70,
2313-2316
[Abstract/Free Full Text]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Binder, G. Liebisch, T. Langmann, and G. Schmitz
Metabolic Profiling of Glycerophospholipid Synthesis in Fibroblasts Loaded with Free Cholesterol and Modified Low Density Lipoproteins
J. Biol. Chem.,
August 4, 2006;
281(31):
21869 - 21877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Chirinos, J. P. Zambrano, S. Chakko, A. Schob, R. B. Goldberg, G. Perez, and A. J. Mendez
Ability of Serum to Decrease Cellular AcylCoA:Cholesterol Acyl Transferase Activity Predicts Cardiovascular Outcomes
Circulation,
October 18, 2005;
112(16):
2446 - 2453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Virmani, F. D. Kolodgie, A. P. Burke, A. V. Finn, H. K. Gold, T. N. Tulenko, S. P. Wrenn, and J. Narula
Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2005;
25(10):
2054 - 2061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, A. B. Castoreno, W. Stockinger, and A. Nohturfft
Modulation of Endosomal Cholesteryl Ester Metabolism by Membrane Cholesterol
J. Biol. Chem.,
March 25, 2005;
280(12):
11876 - 11886.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Feng, D. Zhang, G. Kuriakose, C. M. Devlin, M. Kockx, and I. Tabas
Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis
PNAS,
September 2, 2003;
100(18):
10423 - 10428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Wang and A. R. Tall
Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2003;
23(7):
1178 - 1184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T. Remaley, F. Thomas, J. A. Stonik, S. J. Demosky, S. E. Bark, E. B. Neufeld, A. V. Bocharov, T. G. Vishnyakova, A. P. Patterson, T. L. Eggerman, et al.
Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway
J. Lipid Res.,
April 1, 2003;
44(4):
828 - 836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Feng and I. Tabas
ABCA1-mediated Cholesterol Efflux Is Defective in Free Cholesterol-loaded Macrophages. MECHANISM INVOLVES ENHANCED ABCA1 DEGRADATION IN A PROCESS REQUIRING FULL NPC1 ACTIVITY
J. Biol. Chem.,
November 1, 2002;
277(45):
43271 - 43280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Okazaki, J.-i. Osuga, K. Tsukamoto, N. Isoo, T. Kitamine, Y. Tamura, S. Tomita, M. Sekiya, N. Yahagi, Y. Iizuka, et al.
Elimination of Cholesterol Ester from Macrophage Foam Cells by Adenovirus-mediated Gene Transfer of Hormone-sensitive Lipase
J. Biol. Chem.,
August 23, 2002;
277(35):
31893 - 31899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Gillotte-Taylor, M. Nickel, W. J. Johnson, O. L. Francone, P. Holvoet, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips
Effects of Enrichment of Fibroblasts with Unesterified Cholesterol on the Efflux of Cellular Lipids to Apolipoprotein A-I
J. Biol. Chem.,
March 29, 2002;
277(14):
11811 - 11820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. de la Llera-Moya, M. A. Connelly, D. Drazul, S. M. Klein, E. Favari, P. G. Yancey, D. L. Williams, and G. H. Rothblat
Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL
J. Lipid Res.,
December 1, 2001;
42(12):
1969 - 1978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Yao and I. Tabas
Free Cholesterol Loading of Macrophages Is Associated with Widespread Mitochondrial Dysfunction and Activation of the Mitochondrial Apoptosis Pathway
J. Biol. Chem.,
November 2, 2001;
276(45):
42468 - 42476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mori, H. Itabe, Y. Higashi, Y. Fujimoto, M. Shiomi, M. Yoshizumi, Y. Ouchi, and T. Takano
Foam cell formation containing lipid droplets enriched with free cholesterol by hyperlipidemic serum
J. Lipid Res.,
November 1, 2001;
42(11):
1771 - 1781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Venkateswaran, J. J. Repa, J.-M. A. Lobaccaro, A. Bronson, D. J. Mangelsdorf, and P. A. Edwards
Human White/Murine ABC8 mRNA Levels Are Highly Induced in Lipid-loaded Macrophages. A TRANSCRIPTIONAL ROLE FOR SPECIFIC OXYSTEROLS
J. Biol. Chem.,
May 5, 2000;
275(19):
14700 - 14707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Prattes, G Horl, A Hammer, A Blaschitz, W. Graier, W Sattler, R Zechner, and E Steyrer
Intracellular distribution and mobilization of unesterified cholesterol in adipocytes: triglyceride droplets are surrounded by cholesterol-rich ER-like surface layer structures
J. Cell Sci.,
January 9, 2000;
113(17):
2977 - 2989.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Rees, T. Sloane, W. Jessup, R. T. Dean, and L. Kritharides
Apolipoprotein A-I Stimulates Secretion of Apolipoprotein E by Foam Cell Macrophages
J. Biol. Chem.,
September 24, 1999;
274(39):
27925 - 27933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mori, H. Itabe, K. Takatoku, K. Shima, J. Inoue, M. Nishiura, H. Takahashi, H. Ohtake, R. Sato, Y. Higashi, et al.
Presence of Phospholipid-Neutral Lipid Complex Structures in Atherosclerotic Lesions as Detected by a Novel Monoclonal Antibody
J. Biol. Chem.,
August 27, 1999;
274(35):
24828 - 24837.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G. Jerome, C. Cash, R. Webber, R. Horton, and P. G. Yancey
Lysosomal lipid accumulation from oxidized low density lipoprotein is correlated with hypertrophy of the Golgi apparatus and trans-Golgi network
J. Lipid Res.,
July 1, 1998;
39(7):
1362 - 1371.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. P. Eberhart, A. J. Mendez, and M. W. Freeman
Decreased Cholesterol Efflux from Fibroblasts of a Patient without Tangier Disease, but with Markedly Reduced High Density Lipoprotein Cholesterol Levels
J. Clin. Endocrinol. Metab.,
March 1, 1998;
83(3):
836 - 846.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Kellner-Weibel, W. G. Jerome, D. M. Small, G. J. Warner, J. K. Stoltenborg, M. A. Kearney, M. H. Corjay, M. C. Phillips, and G. H. Rothblat
Effects of Intracellular Free Cholesterol Accumulation on Macrophage Viability : A Model for Foam Cell Death
Arterioscler. Thromb. Vasc. Biol.,
March 1, 1998;
18(3):
423 - 431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Marathe, S. L. Schissel, M. J. Yellin, N. Beatini, R. Mintzer, K. J. Williams, and I. Tabas
Human Vascular Endothelial Cells Are a Rich and Regulatable Source of Secretory Sphingomyelinase. IMPLICATIONS FOR EARLY ATHEROGENESIS AND CERAMIDE-MEDIATED CELL SIGNALING
J. Biol. Chem.,
February 13, 1998;
273(7):
4081 - 4088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Tang, G. A. Keesler, and I. Tabas
The Structure of the Gene for Murine CTP:Phosphocholine Cytidylyltransferase, Ctpct. RELATIONSHIP OF EXON STRUCTURE TO FUNCTIONAL DOMAINS AND IDENTIFICATION OF TRANSCRIPTIONAL START SITES AND POTENTIAL UPSTREAM REGULATORY ELEMENTS
J. Biol. Chem.,
May 16, 1997;
272(20):
13146 - 13151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Yao and I. Tabas
Free Cholesterol Loading of Macrophages Induces Apoptosis Involving the Fas Pathway
J. Biol. Chem.,
July 28, 2000;
275(31):
23807 - 23813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zhang, W. Tang, P. M. Yao, C. Yang, B. Xie, S. Jackowski, and I. Tabas
Macrophages Deficient in CTP:Phosphocholine Cytidylyltransferase-alpha Are Viable under Normal Culture Conditions but Are Highly Susceptible to Free Cholesterol-induced Death. MOLECULAR GENETIC EVIDENCE THAT THE INDUCTION OF PHOSPHATIDYLCHOLINE BIOSYNTHESIS IN FREE CHOLESTEROL-LOADED MACROPHAGES IS AN ADAPTIVE RESPONSE
J. Biol. Chem.,
November 3, 2000;
275(45):
35368 - 35376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Leventhal, W. Chen, A. R. Tall, and I. Tabas
Acid Sphingomyelinase-deficient Macrophages Have Defective Cholesterol Trafficking and Efflux
J. Biol. Chem.,
November 21, 2001;
276(48):
44976 - 44983.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|